Polypid logo

Polypid share price today

(PYPD)

Polypid share price is $3.22 & ₹273.62 as on 21 Dec 2024, 2.30 'hrs' IST

$3.22

-0.28

(-8%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Polypid share price in Dollar and Rupees. Guide to invest in Polypid from India. Also see the sentimental analysis on Indian investors investing in Polypid. Get details on the Indian mutual funds that are investing in Polypid. Get Analyst recommendations and forecasts along with all the Polypid's financials.

Polypid share price movements

  • Today's Low: $3.22
    Today's High: $3.68

    Day's Volatility :12.5%

  • 52 Weeks Low: $2.37
    52 Weeks High: $9.20

    52 Weeks Volatility :74.24%

Polypid Returns

PeriodPolypid LtdIndex (Russel 2000)
3 Months
1.45%
0.0%
6 Months
-12.06%
0.0%
1 Year
-8.16%
0.0%
3 Years
-98.06%
-17.3%

Polypid Key Statistics

in dollars & INR

Previous Close
$3.5
Open
$3.5
Today's High
$3.68
Today's Low
$3.22
Market Capitalization
$19.5M
Today's Volume
$34.8K
52 Week High
$9.2
52 Week Low
$2.37
Revenue TTM
$0.0
EBITDA
$-21.9M
Earnings Per Share (EPS)
$-7.22
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-496.62%

How to invest in Polypid from India?

It is very easy for Indian residents to invest directly in Polypid from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Polypid stock in both Indian Rupees (INR) and US Dollars (USD). Search for Polypid or PYPD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Polypid or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Polypid shares which would translate to 0.264 fractional shares of Polypid as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Polypid, in just a few clicks!

Returns in Polypid for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Polypid investment value today

Current value as on today

₹1,17,581

Returns

₹17,581

(+17.58%)

Returns from Polypid Stock

₹15,486 (false-15.49%)

Dollar Returns

₹2,095 (+2.1%)

Indian investors sentiment towards Polypid

20%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Polypid on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 20% more investors are searching Polypid in the last 30 days versus the previous period.

Global Institutional Holdings in Polypid

  • AIGH Capital Management, LLC

    9.99%

  • Rosalind Advisors, Inc.

    9.98%

  • Dafna Capital Management LLC

    4.53%

  • Stonepine Capital Management Llc

    2.04%

  • ADAR1 Capital Management LLC

    1.38%

  • Yelin Lapidot Holdings Management Ltd

    0.16%

Analyst Recommendation on Polypid

Buy

    77%Buy

    22%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Polypid(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Polypid

What analysts predicted

Upside of 264.91%

Current:

$3.22

Target:

$11.75

Insights on Polypid

  • Price Movement

    In the last 7 days, PYPD stock has moved up by 34.1%
  • PYPD vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 33.4% return, outperforming this stock by 44.3%
  • PYPD vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 20.5% return, outperforming this stock by 118.5%

Polypid Technicals Summary

Sell

Neutral

Buy

Polypid is currently in a neutral trading position according to technical analysis indicators.

Polypid Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Polypid Ltd
0.29%
-12.06%
-8.16%
-98.06%
-99.39%
Regeneron Pharmaceuticals, Inc.
-4.72%
-33.43%
-16.35%
14.7%
89.27%
Biontech Se
9.01%
28.55%
5.71%
-57.13%
220.59%
Alnylam Pharmaceuticals, Inc.
-3.99%
7.16%
25.05%
27.48%
103.59%
Vertex Pharmaceuticals Incorporated
-12.1%
-16.49%
-2.12%
78.05%
80.31%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Polypid Ltd
NA
NA
NA
-4.91
-4.97
-0.65
NA
-1.27
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.05
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Polypid Ltd
Buy
$19.5M
-99.39%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
89.27%
17.67
33.61%
Biontech Se
Buy
$26.8B
220.59%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.7B
103.59%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$115.2B
80.31%
32.84
-4.51%

About Polypid

polypid®, a specialty pharmaceutical company, develops and manufactures products based on its plex™ technology. so far, 70 patients have been treated in clinical trials with polypid’s anti-infection products demonstrating safety and efficacy. polypid is in the process of submitting its lead product for phase-iii trial in the us and eu. plex™ is able to optimize drugs'​ therapeutic performance and clinical outcomes. plex™-based protected drug reservoir is implanted directly into the body’s target area thus enabling prolonged delivery of drugs, over periods ranging from days to several months. polypid’s pipeline focuses on 3 products: d-plex™ - intended for prevention and treatment of surgical infections caused by bacteria. its effectiveness is currently being tested in patients undergoing open-heart surgery, with a view to preventing infections that may occur following surgery. the product is currently undergoing clinical studies at several medical centers. bonypid®-1000 - designed to e
Organization
Polypid
Employees
59
CEO
Ms. Dikla Czaczkes Akselbrad
Industry
Health Technology

Management People of Polypid

NameTitle
Ms. Dikla Czaczkes Akselbrad
CEO & Director
Mr. Jonny Missulawin
Chief Financial Officer
Ms. Dalit Hazan
Deputy CEO and Executive VP of R&D, Clinical & Regulatory Affairs
Mr. Ori Warshavsky
Chief Operating Officer - US
Ms. Maria Rubin
Vice President of Operations
Mr. Tal Vilnai
General Counsel & Corporate Secretary
Ms. Rivi Lev-ari
Vice President of Human Resource
Dr. Jean-Marc Hagai Pharm.D.
Chief Commercial Officer

Important FAQs about investing in Polypid from India :

What is Polypid share price today?

Polypid share price today stands at $3.22, Open: $3.50 ; Previous Close: $3.50 ; High: $3.68 ; Low: $3.22 ; 52 Week High: $9.20 ; 52 Week Low: $2.37. The stock opens at $3.50, after a previous close of $3.50. The stock reached a daily high of $3.68 and a low of $3.22, with a 52-week high of $9.20 and a 52-week low of $2.37.

Can Indians buy Polypid shares?

Yes, Indians can invest in the Polypid (PYPD) from India.

With INDmoney, you can buy Polypid at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Polypid at zero transaction cost.

How can I buy Polypid shares from India?

It is very easy to buy Polypid from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Polypid be purchased?

Yes, you can buy fractional shares of Polypid with INDmoney app.

What are the documents required to start investing in Polypid stocks?

To start investing in Polypid, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Polypid

Today’s highest price of Polypid (PYPD) is $3.68.

Today’s lowest price of Polypid (PYPD) is $3.22.

What is today's market capitalisation of Polypid

Today's market capitalisation of Polypid PYPD is 19.5M

What is the 52 Week High and Low Range of Polypid

  • 52 Week High

    $9.20

  • 52 Week Low

    $2.37

What are the historical returns of Polypid?

  • 1 Month Returns

    0.29%

  • 3 Months Returns

    -12.06%

  • 1 Year Returns

    -8.16%

  • 5 Years Returns

    -99.39%

Who is the Chief Executive Officer (CEO) of Polypid

Ms. Dikla Czaczkes Akselbrad is the current Chief Executive Officer (CEO) of Polypid.